Glycosylated cationic liposomes for cell-selective gene delivery

Area of Science:

• Biotechnology
• Nanomedicine
• Gene Therapy

Background:

• Cationic liposomes offer a nonviral gene delivery alternative with lower immunogenicity than viral vectors.
• Current limitations include lower gene transfer efficiency and lack of organ/cell selectivity, often resulting in lung accumulation.
• Cell-specific targeting is crucial for improving in vivo gene delivery and minimizing side effects.

Purpose of the Study:

• To evaluate a gene delivery system using plasmid DNA/glycosylated cationic complexes.
• To investigate the role of physicochemical properties in achieving cell-selective targeting.
• To enhance gene expression levels and reduce off-target effects.

Main Methods:

• Development of glycosylated cationic liposome complexes with plasmid DNA.
• Assessment of physicochemical properties of the formed complexes.
• Evaluation of cell-selective targeting using receptor-mediated pathways (asialoglycoprotein and mannose receptors).
• Analysis of gene expression levels in specific cell types in vivo.

Main Results:

• Physicochemical properties of plasmid DNA/glycosylated cationic complexes significantly influence cell-selective targeting.
• Successful targeting of liver parenchymal and non-parenchymal cells was demonstrated.
• Optimized complexes showed enhanced gene expression compared to non-targeted systems.

Conclusions:

• Effective cell-selective gene delivery requires optimization of both ligand type and overall complex physicochemical properties.
• Glycosylated cationic liposomes represent a viable strategy for targeted gene delivery.
• Further research into optimizing these complexes can lead to improved gene therapy applications.